Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-17-006369
Filing Date
2017-02-07
Accepted
2017-02-07 10:30:17
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1/A v458551_s1a.htm S-1/A 1196689
2 EXHIBIT 1.1 v458551_ex1-1.htm EX-1.1 222295
3 EXHIBIT 4.1 v458551_ex4-1.htm EX-4.1 101338
4 EXHIBIT 5 v458551_ex5.htm EX-5 11889
5 EXHIBIT 23.1 v458551_ex23-1.htm EX-23.1 2806
6 GRAPHIC pg64img1_s1.jpg GRAPHIC 75132
7 GRAPHIC pg66img1_s1.jpg GRAPHIC 107913
8 GRAPHIC pg67img1_s1.jpg GRAPHIC 33583
9 GRAPHIC pg60img1_s1.jpg GRAPHIC 16568
  Complete submission text file 0001144204-17-006369.txt   1857733
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-214898 | Film No.: 17577552
SIC: 2834 Pharmaceutical Preparations